Cost Effectiveness of the Shorter Course MDR TB Regimen (SCR) for multi-drug resistant tuberculosis (MDR TB) treatment
Principal investigator
-
Location
-
Topic
-
Methodology
-
ReferenceOCA017-50
Purpose of study
Purpose of study
The primary outcome of this study is to compare the programmatic cost and health outcome differences between patients with rifampicin-resistant (RR) and MDR-TB treated with the SCR and those treated with conventional regimens in high TB prevalent ...
-
Concept
-
Protocol & ERB
-
Implementation
-
Completion
-
Archived
Study timeline
-
Publication added by Holly Baker
3rd August 2022 -
Publication added by Sree
7th March 2022 -
Concept paper added
19th October 201720170607_SCR_costing_Piggott_v4_JA_clean.doc401 KB
Documents
Publications
-
Program costs of longer and shorter tuberculosis drug regimens and drug import: A modelling study for Karakalpakstan, UzbekistanKohler, Stefan "–" European Respiratory Society (ERS) "(2022)"
-
The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, UzbekistanKohler, Stefan "–" Public Library of Science (PLoS) "(2022)"